A total of 108 patients were included: 84% Spoke-IHS and 16% Hub-HIS. Baseline characteristics were comparable between the two groups. Mean time to last seen well (TLSW) to recognition (TR) was lower in the Hub population (61 vs.72 min, p=.73). TLSW to imaging was lower (83 vs. 99 min, p=.55). Imaging to tPA was lower (17 vs. 70.4 min, p<.05). Average TLSW to groin puncture was lower (120 vs. 213 min, p<.05). There was increased early improvement in NIHSS (41% vs 31%, p=.4) and decreased early deterioration (11% vs. 15%, p=.7). Rates of symptomatic hemorrhage or parenchymatous hematoma-2 were lower (0 vs.11%). TPA rates were higher (29.4% vs. 16.5%, p=.21). Mortality at discharge was lower in the Hub population (23.5% vs. 32%, p=.49). At 90 days, this was 41.2% vs. 46.5%, respectively (p=.69). Of those with a baseline mRS of 0-2, 28.6% of Hub-HIS had mRS of 0-2 at 90 days vs. 11.7% (p=.1) at Spoke and these were increased to 57.1% and 22.1%, respectively when including mRS of 3 at 90 days (p<0.05).